A long-term, open-label extension study on the safety of treatment with lanthanum carbonate, a new phosphate binder, in patients receiving hemodialysis

By Finn William F.   Joy Melanie S.    

Current Medical Research and Opinion, Vol. 21, Iss. 5, 2005-05 ,pp. : 657-664

Informa Healthcare

Access to resources Recommend Favorite

Long-term tolerability and efficacy of the combination of amlodipine/valsartan in hypertensive patients: a 54-week, open-label extension study*

By Philipp Thomas   Glazer Robert D.   Zhao Yanxing   Pospiech Rainer  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 187-193

Informa Healthcare

Access to resources Recommend Favorite

An Open-Label Study of the Long-Term Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (RECAP)

By  

Respiration, Vol. 94, Iss. 5, 2017-09 ,pp. : 408-415

Karger

Access to resources Recommend Favorite

Long-term darifenacin treatment for overactive bladder in patients aged 65 years and older: analysis of results from a 2-year, open-label extension study

By Hill Simon   Elhilali Mostafa   Millard Richard J   Dwyer Peter L   Lheritier Karine   Kawakami Fernando T.   Steel Michael  

Current Medical Research and Opinion, Vol. 23, Iss. 11, 2007-11 ,pp. : 2697-2704

Informa Healthcare

Access to resources Recommend Favorite

Prospective Controlled Cohort Studies on Long-Term Therapy of Breast Cancer Patients with a Mistletoe Preparation (Iscador®)

By  

Forschende Komplementärmedizin / Research in Complementary Medicine, Vol. 13, Iss. 5, 2006-10 ,pp. : 285-292

Karger

Access to resources Recommend Favorite